Screening of Fabry disease in patients with end-stage renal disease of unknown etiology: the first Thailand study.

about

Screening of Fabry disease in patients with end-stage renal disease of unknown etiology: the first Thailand study.

Item

http://www.wikidata.org/entity/Q42136169

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Screening of Fabry disease in ...... ogy: the first Thailand study.

@en

Screening of Fabry disease in ...... ogy: the first Thailand study.

@nl

type

Item

label

Screening of Fabry disease in ...... ogy: the first Thailand study.

@en

Screening of Fabry disease in ...... ogy: the first Thailand study.

@nl

prefLabel

Screening of Fabry disease in ...... ogy: the first Thailand study.

@en

Screening of Fabry disease in ...... ogy: the first Thailand study.

@nl

P1476

Screening of Fabry disease in ...... ogy: the first Thailand study.

@en

P2093

Arkom Nongnuch

http://www.w3.org/2001/XMLSchema#string

Norasak Suvachittanont

http://www.w3.org/2001/XMLSchema#string

Objoon Trachoo

http://www.w3.org/2001/XMLSchema#string

Paisan Jittorntam

http://www.w3.org/2001/XMLSchema#string

Piyatida Chuengsaman

http://www.w3.org/2001/XMLSchema#string

Saowanee Kajanachumphol

http://www.w3.org/2001/XMLSchema#string

Sarunpong Pibalyart

http://www.w3.org/2001/XMLSchema#string

Suthep Patputthipong

http://www.w3.org/2001/XMLSchema#string

P2860

Living donor kidney transplantation in patients with hereditary nephropathies.

Frequency of Fabry disease in male and female haemodialysis patients in Spain.

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype.

Pharmacological chaperone therapy for Fabry disease

Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency.

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.

Prevalence of Fabry disease in stroke patients--a systematic review and meta-analysis.

A search for Fabry disease among male end-stage renal disease patients in Lebanon and a review of the literature.

P304

17-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7555/JBR.31.20160063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28808181

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn

P932

5274508

http://www.w3.org/2001/XMLSchema#string